Supreme court says FTC can sue over deals that delay Generic drug sales

WASHINGTON, June 18: The Supreme Court ruled yesterday regulators can challenge deals between brand-name drug companies and generic rivals that delay cheaper medicines from going on sale, which regulators say increase costs to consumers by billions of dollars. But the court, in a 5-3 vote with Justice Samuel Alito recused, declined the Federal Trade Commission’s request to declare the deals to be presumed to be illegal. The regulatory agency has fought the practice for more than a decade. (agencies)

Follow our WhatsApp channel